Alsaati Alshaimaa M, Alasiri Meshal M, Alansari Bayan A, Mulla Wed Y, Al-Marzouki Adel F, Daous Yara M, Radhwi Osman
Medical School, King Abdulaziz University Hospital, Jeddah, SAU.
Hematology, King Abdulaziz University Hospital, Jeddah, SAU.
Cureus. 2023 Jan 2;15(1):e33239. doi: 10.7759/cureus.33239. eCollection 2023 Jan.
Mantle cell lymphoma (MCL) is a rare subtype of B-cell lymphoma that can present in a variety of ways, including the leukemic phase, where it can occasionally be mistaken for acute leukemia due to the unusually high or rapidly growing number of leukocytes and the presence of circulating cancer cells that are morphologically similar to leukemic blasts in myeloid or acute lymphoblastic leukemia. We present the case of an 83-year-old Yemeni woman with multiple comorbidities who presented with abdominal pain and constitutional symptoms. She was found to have diffuse lymphadenopathy on clinical and radiological assessments. Her white blood cell count at presentation was 221 × 10/L with marked monocytosis (72.8%). Lymph node biopsy and bone marrow studies, including molecular studies, confirmed MCL, the pleomorphic subtype. The patient was deemed unfit for standard-of-care chemotherapy and was started on single-agent rituximab with a slow introduction to ibrutinib but succumbed to death after two weeks of ibrutinib 280 mg daily. This case serves as a reminder to keep an open mind and take into account atypical disease presentations when formulating differential diagnoses to prevent late diagnosis and any unnecessary intervention that can postpone appropriate therapy.
套细胞淋巴瘤(MCL)是B细胞淋巴瘤的一种罕见亚型,可表现为多种形式,包括白血病期,在此阶段,由于白细胞数量异常高或迅速增长,以及存在形态上类似于髓系或急性淋巴细胞白血病中的白血病原始细胞的循环癌细胞,它偶尔会被误诊为急性白血病。我们报告了一例83岁的也门女性病例,她有多种合并症,表现为腹痛和全身症状。临床和影像学评估发现她有弥漫性淋巴结病。她就诊时白细胞计数为221×10⁹/L,单核细胞显著增多(72.8%)。淋巴结活检和骨髓检查,包括分子研究,确诊为MCL,即多形性亚型。该患者被认为不适合标准的化疗方案,开始使用单药利妥昔单抗,并缓慢引入伊布替尼,但在每天服用280mg伊布替尼两周后死亡。这个病例提醒我们,在制定鉴别诊断时要保持开放的思维,考虑到非典型的疾病表现,以防止漏诊以及任何可能推迟适当治疗的不必要干预。